22157.jpg
UAE Eye Care Market Report 2022: Featuring EssilorLuxottica, Bausch Health Companies, Johnson & Johnson & Others
October 04, 2022 06:33 ET | Research and Markets
Dublin, Oct. 04, 2022 (GLOBE NEWSWIRE) -- The "UAE Eye Care Market, By Product Type (Eyeglasses, Contact Lens, Intraocular Lens, Eye Drops, Eye Vitamins, Others), By Coating (Anti-Glare, UV,...
tarsus-logo-stacked-color-532x626.png
Tarsus to Present Saturn-2 Pivotal Phase 3 Trial Data and Saturn-1 Extension Study Long-Term Safety Data Evaluating TP-03 for the Treatment of Demodex Blepharitis at Upcoming Eye Care Meetings
September 27, 2022 12:00 ET | Tarsus Pharmaceuticals, Inc
Positive data to be presented at WCC VIII and AAO 2022 conferences in Chicago Tarsus recently submitted NDA to the FDA for TP-03 IRVINE, Calif., Sept. 27, 2022 (GLOBE NEWSWIRE) -- Tarsus...
Vision Benefits of America Announces Hearing Care Program With HearUSA
September 06, 2022 22:16 ET | VBA
PITTSBURGH, Sept. 06, 2022 (GLOBE NEWSWIRE) -- Vision Benefits of America, Inc. (VBA), a commercial group benefits organization, today announced a hearing care program with HearUSA, a network of...
Axim-Sapphire_Logo_-04 (1).png
AXIM Biotechnologies Celebrates Feature on the Vision is More Than 20/20™ Podcast
July 21, 2022 09:00 ET | AXIM BIOTECHNOLOGIES, INC
SAN DIEGO, July 21, 2022 (GLOBE NEWSWIRE) -- AXIM Biotechnologies, Inc. (OTCQB: AXIM) (“AXIM Biotech,” “AXIM” or “the Company”), an international healthcare solutions company targeting ocular...
$5.7 Billion Worldwide Therapeutics Contact Lens Industry to 2027 - Increased Prevalence of Myopia and Other Eye Disorders is Driving Growth
June 24, 2022 06:03 ET | Research and Markets
Dublin, June 24, 2022 (GLOBE NEWSWIRE) -- The "Global Therapeutics Contact Lens Market, By Material Type (Balafilcon, Lotrafilcon, Methafilcon, Senofilcon, Others), By Application (Pain Relief,...
Axim-Sapphire_Logo_-04 (1).png
AXIM Launches New Eye Care Website; Establishes Platform for Commercialization
June 02, 2022 09:00 ET | AXIM BIOTECHNOLOGIES, INC
SAN DIEGO, June 02, 2022 (GLOBE NEWSWIRE) -- AXIM Biotechnologies, Inc (OTCQB: AXIM) (“AXIM Biotech,” “AXIM” or “the Company”), an international healthcare solutions company targeting ocular surface...
22157.jpg
Insights on the Eye Drops Industry in Saudi Arabia to 2027 - by Type, Drug Class, Disease Indication, Distribution Channel, End-user and Region
June 02, 2022 04:33 ET | Research and Markets
Dublin, June 02, 2022 (GLOBE NEWSWIRE) -- The "Saudi Arabia Eye Drops Market, By Type (Prescription v/s Over-The-Counter), By Drug Class (Antiallergy, Anti-inflammatory, Antiglaucoma, Anti-VEGF,...
Digital Vision Screening Platform Aims to Decrease Vision Loss Rates for Patients With Eye Disorders
May 24, 2022 11:00 ET | Retina Technologies, Inc
NEW YORK, May 24, 2022 (GLOBE NEWSWIRE) -- Retina Technologies, Inc. ("RetTech") is advancing the development of OcuVue™, an affordable, digital vision screening platform with integrated...
Axim-Sapphire_Logo_-04 (1).png
AXIM Biotechnologies Completes Optimization of Only FDA-Cleared IgE Rapid Diagnostics Test – In-House Manufacturing Lowers Cost and Eliminates Supply Chain Expenditures
May 24, 2022 09:00 ET | AXIM BIOTECHNOLOGIES, INC
SAN DIEGO, May 24, 2022 (GLOBE NEWSWIRE) -- AXIM Biotechnologies, Inc (OTCQB: AXIM) (“AXIM Biotech,” “AXIM” or “the Company”), an international healthcare solutions company targeting ocular surface...
Axim-Sapphire_Logo_-04 (1).png
AXIM Biotechnologies Develops Novel Tear Sample Collector System, Files Patent Application
May 10, 2022 09:00 ET | AXIM BIOTECHNOLOGIES, INC
SAN DIEGO, May 10, 2022 (GLOBE NEWSWIRE) -- AXIM Biotechnologies, Inc (OTCQB: AXIM) (“AXIM Biotech,” “AXIM” or “the Company”), an international healthcare solutions company targeting dry eye disease...